Physician profile
Steven A Johnson
NPI 1295763027
$1,712.67
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $193 · 2021: $270 · 2022: $290 · 2024: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $631.49 | 2019-2024 | Ams 700 |
| Astellas Pharma US INC | $189.29 | 2019 | |
| 180 Medical, INC. | $157.83 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $144.48 | 2020-2022 | |
| Teleflex LLC | $111.58 | 2024 | Urolift |
| Medtronic USA, INC. | $97.32 | 2019 | |
| Healthtronics Stone Solutions, LLC | $66.00 | 2019 | |
| Abbvie INC. | $55.14 | 2019-2022 | |
| Blue Earth Diagnostics | $42.59 | 2019-2020 | |
| Antares Pharma, INC. | $37.13 | 2019-2021 | |
| Convatec INC. | $33.21 | 2021-2022 | |
| Pfizer INC. | $31.22 | 2021 | |
| Allergan, INC. | $24.86 | 2019 | |
| Coloplast Corp | $22.74 | 2022 | |
| Axonics, INC. | $21.75 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $15.81 | 2021 | |
| Travere Therapeutics, INC. | $15.63 | 2019 | |
| Urovant Sciences INC | $14.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.